Inovio’s DNA vaccine for Zika virus induces robust responses
17 February 2016 | By Victoria White
In preclinical studies, Inovio's Zika DNA vaccine resulted in seroconversion, or the development of detectable specific antibodies in the blood...
List view / Grid view
News
TAxI holds promise as a carrier for spinal cord treatments
17 February 2016 | By Victoria White
The small peptide has been shown to be an effective at shuttling functional proteins into the spinal cord after a muscle injection...
Scientists discover dual role of IL-36 in inflammatory bowel disease
17 February 2016 | By Victoria White
Scientists have discovered the dual role of IL-36 in both promoting intestinal inflammation and resolving or healing that inflammation in IBD...
Zika virus must be addressed using a multi-pronged approach, says GlobalData
16 February 2016 | By Victoria White
A GlobalData analyst says that while a Zika virus vaccine could be an effective measure in the long term, it remains several years away...
Forbion invests in Akarna Therapeutics’ $15 Million Series B Financing
16 February 2016 | By Victoria White
Akarna has said it will use the funds to accelerate the development of its lead FXR agonist drug candidate...
‘Extraordinary’ t-cell cancer therapy results generate excitement
16 February 2016 | By Victoria White
In one study, the engineered T-cells induced complete remission in 94% of patients with acute lymphoblastic leukaemia...
BMS and Dana-Farber Cancer Institute enter I-O RPM collaboration
16 February 2016 | By Victoria White
As part of the I-O RPM programme, Bristol-Myers Squibb and Dana-Farber Cancer Institute will conduct a range of early phase clinical studies...
MGB Biopharma and Strathclyde to develop new MGB anti-infectives
16 February 2016 | By Victoria White
MGB Biopharma and the University of Strathclyde are to extend their existing collaboration to develop novel MGB anti-infectives...
AbbVie announced as the latest Dementia Consortium partner
16 February 2016 | By Victoria White
AbbVie has been announced as the latest Dementia Consortium partner, joining MRC Technology, Alzheimer’s Research UK, Astex, Eisai and Lilly...
Drug discovery crisis linked to bad technology choices
15 February 2016 | By Victoria White
Researchers say drug discovery processes are becoming unsustainably expensive despite huge technological advances because the wrong methods are being used…
Eisai and Charles River announce drug discovery collaboration
15 February 2016 | By Victoria White
Eisai and Charles River have signed a collaboration agreement which will see Charles River scientists work at Eisai’s research and development facilities in Hatfield...
Herpesvirus CMV-based vaccine shown to be effective against Ebola
15 February 2016 | By Victoria White
In addition to establishing the potential for CMV-based vaccines against Ebola virus, these results are exciting from the potential insight they give into the mechanism of protection...
Vaccines and alternatives can play a role in tackling drug-resistant infections
12 February 2016 | By Victoria White
The latest report from the Review on Antimicrobial Resistance says that vaccines and other alternatives can play a vital role in tackling the rise of drug-resistant infections...
Nimbolide shows potential as pancreatic cancer treatment
12 February 2016 | By Victoria White
Scientists tested nimbolide, natural extract derived from India's neem tree, against pancreatic cancer in cell lines and mice...
FGF21 discovery could lead to new treatments for type 2 diabetes
11 February 2016 | By Victoria White
New research on the blood lipid-lowering protein FGF21 shows how it redistributes fatty acids by two distinct mechanisms...
